A
1.26
0.00 (0.00%)
| Penutupan Terdahulu | 1.26 |
| Buka | 1.23 |
| Jumlah Dagangan | 166,512 |
| Purata Dagangan (3B) | 2,052,185 |
| Modal Pasaran | 19,380,816 |
| Harga / Jualan (P/S) | 205.85 |
| Harga / Buku (P/B) | 1.58 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -5,822.92% |
| EPS Cair (TTM) | -2.89 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 75.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 149.87% |
| Nisbah Semasa (MRQ) | 2.89 |
| Aliran Tunai Operasi (OCF TTM) | -29.93 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -28.82 M |
| Pulangan Atas Aset (ROA TTM) | -82.76% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | Adagio Medical Holdings, Inc | - | - |
AISkor Stockmoo
-1.8
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -3.0 |
| Purata | -1.75 |
|
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| % Dimiliki oleh Orang Dalam | 0.29% |
| % Dimiliki oleh Institusi | 85.46% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 15 May 2025 | Pengumuman | Adagio Medical Reports First Quarter 2025 Results |
| 07 May 2025 | Pengumuman | Adagio Medical to Present at the BofA Securities 2025 Health Care Conference |
| 17 Apr 2025 | Pengumuman | Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System |
| 31 Mar 2025 | Pengumuman | Adagio Medical Reports Fourth Quarter and Full Year 2024 Results |
| 31 Mar 2025 | Pengumuman | Adagio Medical Appoints Deborah Kaster as Chief Business Officer |
| 17 Mar 2025 | Pengumuman | Adagio Medical Provides Clinical and Business Updates |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |